This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Principe, P. Articles by Braquet, P. Search for Related Content PubMed PubMed Citation Articles by Principe, P. Articles by Braquet, P.

Tumor Cell Kinetics following Antineoplastic Ether Phospholipid Treatment¹

Institut Henri Beaufour Research Laboratories, 1, Avenue des Tropiques, 91952 Les Ulis, France

Ether phospholipids are analogues of the naturally occurring 2-lysophosphatidylcholine that have been reported to have in vitro/in vivo antitumor activity. Their antiproliferative effect has been found against a variety of animal and human tumor cell lines. We have characterized the cytostatic activity of two ether phospholipids, 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine and 1-hexadecylmercapto-2-methoxymethyl-rac-glycero-3-phosphocholine, on a human tumor cell line derived from a colon adenocarcinoma, HT29. We have used three different flow cytometric approaches to study which phase of the cell cycle was the most sensitive to the antiproliferative activity of the two ether phospholipids. By applying the biparametric analysis, 5'-bromo-2-deoxyuridine incorporation versus DNA content, we have been able to demonstrate that ether phospholipids do not interfere with the S phase of the cell cycle. The simultaneous measurement of total nuclear protein versus DNA content in isolated HT29 nuclei has enabled us to exclude a block in the M phase of the cell cycle. Finally, the stathmokinetic analysis has allowed us to show that the cytostatic activity of the two ether phospholipids 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine and 1-hexadecylmercapto-2-methoxymethyl-rac-glycero-3-phosphocholine is characterized by multiple "terminal points" as the drugs action results in a G₁ block and in a slow-down of the transition from late S to G₂, followed by an accumulation of HT29 cells in the G₂ phase of the cell cycle.

¹ Part of the data presented in this paper were communicated at the 81st Annual Meeting of the American Association for Cancer Research, Washington, DC, May 23–26, 1990 (Proc. Am. Assoc. Cancer Res., 31: 415, 1990).

² To whom requests for reprints should be addressed.

Received 10/ 7/91. Accepted 2/25/92.

This article has been cited by other articles:

				S. P. Whitman, F. Civoli, and L. W. Daniel Protein Kinase Cbeta II Activation by 1-beta -D-Arabinofuranosylcytosine Is Antagonistic to Stimulation of Apoptosis and Bcl-2alpha Down-regulation J. Biol. Chem., September 19, 1997; 272(38): 23481 - 23484. [Abstract] [Full Text] [PDF]